Skip to content

Keziya Mathew

NPI 1285205542ActiveIndividual· Internal Medicine, Rheumatology· Worcester, MA

Internal Medicine, Rheumatology in Worcester, Massachusetts, licensed in MO and MA, with an NPI issued in July 2021. Part D covered 122 prescriptions written in 2024, 92% of them generic. Novartis Pharmaceuticals Corporation reported $29.19 in payments in 2025, mostly food and beverage.

Overview

NPI1285205542
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJul 8, 2021
Last updated in NPPESSep 22, 2026
Certified by providerSep 22, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (MO)

Part D prescriptions in 2024

Prescriptions (claims)122 · 198 30-day fills
Patients55
Total drug cost$71,468
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$29.19 · 1 payment from 1 company
  • 2024$199.35 · 9 payments from 7 companies

Top paying companies in 2025

CompanyAmountPayments
Novartis Pharmaceuticals Corporation$29.191

What the 2025 payments were for

  • Food and Beverage$29.19 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other rheumatologists in Worcester

All 46 rheumatologists in Worcester · All rheumatologists in Massachusetts